Press enter to begin your search

Arix Bioscience - Interview with VelosBio CEO

ARIX
Wed, 04 Dec 2019, 09:10am GMT

Dave Johnson, CEO of VelosBio, discusses how VelosBio is developing novel anti-body drug conjugates to target sold tumours.

Arix Bioscience
Management Team
ARIX
5d9f460634a3cf1389e7d1c3
SHOW MORE
FROM THIS COMPANY
Arix Bioscience - Interview with VelosBio CEO
ARIX Wed, 04 Dec 2019, 09:10am GMT

Arix Bioscience is a healthcare and life science company that drives value in private and public companies through operational and strategic support and direction as well as patient capital.

Industry: Financial Services

Contact: +44 (0)20 7290 1050
20 Berkeley Square, London, W1J 6EQ, United Kingdom

Dave Johnson, CEO of VelosBio, discusses how VelosBio is developing novel anti-body drug conjugates to target sold tumours.

Arix Bioscience
Management Team
POWERED BY